Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
ITabMed
company
About
ITabMed's aim of "Innovating for Life" continues, with a focus on the discovery and development of cancer immunotherapy treatments.
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $20M
- Industries
- Biopharma,Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2020
- Operating Status
- Active
ITabMed is a clinical-stage biotech company located in Shanghai, China. The company was founded in 2020 and is registered in Lin Gang Sci-Tech City, Shanghai. It was a spin-off entity from the former “Generon BioMed Ltd.”. The company is focused on immunotherapy drug research and development to treat cancer.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$20M
ITabMed has raised a total of
$20M
in funding over 2 rounds. Their latest funding was raised on
Dec 1, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 1, 2021 | Series A | $20M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
ITabMed is funded by 1 investors.
Binhai Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Binhai Capital
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
